Post-stenting Antithrombotic Drug Therapy in Patients with Atrial Fibrillation

American Journal of Medicine

Volumn 120, Issue 11, 2007, Pages 920-922

  Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

BLEEDING; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG ELUTING STENT; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MONOTHERAPY; PRIORITY JOURNAL; RISK ASSESSMENT;

ASPIRIN; ATRIAL FIBRILLATION; FIBRINOLYTIC AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; STENTS; THROMBOSIS; TICLOPIDINE; WARFARIN;

EID: 35548960415     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.01.036     Document Type: Editorial

References (5)

1. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 (2006) 119-125
2. Silber S., Albertsson P., Aviles F.F., et al., Task Force for Percutaneous Coronary Intervention of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. Eur Heart J 26 (2005) 804-847
3. Lip G.Y., and Karpha M. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest 130 (2006) 1823-1827
4. Fuster V., Rydén L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation.). J Am Coll Cardiol 48 (2006) e149-e246
5. Flaker G.C., Gruber M., Connolly S.J., et al., SPORTIF investigators. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Am Heart J 152 (2006) 967-973